Blog

C. R. Bard v. Angiodynamics – It’s a Labelled Injection Port, not a Label
Blog

Immunex v. Sanofi-Aventis – The “Mystery Dance” of Claim Construction
Blog

Biogen v. EMD Serono – “A Nest of Limitations”
Blog

The Patent Value Problem and the Case for Design-Around
Blog

USPTO Announces Program to Eliminate Filing Fees in Exchange for Early Publication of COVID-19 Applications
Blog

XY, LLC v. Trans Ova Genetics, Inc. – Building on Illumina v. Ariosa
Blog

Fed. Cir. Panel Holds that Judge Dyk Erred in Construction of Antibody Claims
Blog

AAM v. Neapco – Part IV – Petition for Rehearing En Banc Denied – “Bad Vibrations”
Blog

AAM v. Neapco – Part III – The Dissent Faces a “Perfect Storm” of Conflated Doctrines
Blog

AAM v. Neapco Part II– Judge Moore’s Dissent – Nothing More = Nevermore?
Blog

AAM v. Neapco: Method of Manufacturing Claim Gets the 101 Hook(e)
Blog
